文献速递中医内科针灸推拿中药与中成药合理使用

传统、补充与整合医学在缺血性卒中管理中的叙述性综述

Traditional, complementary, and integrative medicine in the management of ischemic stroke: a narrative review.
PubMed 文献 · Front Pharmacol · 2025-05-30

本文为叙述性综述,评估草药、针灸及心身干预等传统补充与整合医学(TCIM)用于缺血性卒中辅助治疗的现有证据,重点关注丹参、银杏叶和人参的神经保护、抗炎、抗氧化及脑血管效应,并讨论作用机制、临床试验结果与整合挑战。

要点

  • TCIM(草药、针灸、心身干预)被探索作为缺血性卒中的辅助治疗。
  • 丹参、银杏叶和人参是研究较多的植物干预,具有潜在神经保护等效应。
  • 将TCIM整合入常规卒中方案需标准化、质量控制和严格科学验证。

核心结论

  • TCIM作为缺血性卒中辅助治疗有潜在神经保护、抗炎、抗氧化和脑血管效应,但需标准化和严格验证。

研究设计与样本

  • 叙述性综述,评估TCIM用于缺血性卒中的现有证据。

主要发现

  • 草药、针灸和心身干预被探索作为卒中管理的辅助疗法。
  • 丹参、银杏叶和人参是研究较多的植物干预,具有潜在神经保护等效应。

临床怎么用

  • 支持将循证TCIM实践整合入常规卒中护理方案的知情决策。

局限性

  • TCIM的整合面临标准化、质量控制和严格科学验证的挑战。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Ischemic stroke remains a leading cause of mortality and long-term disability worldwide, despite advancements in acute intervention and rehabilitation strategies. Traditional, Complementary, and Integrative Medicine (TCIM) systems; including herbal medicine, acupuncture, and mind-body interventions are increasingly being explored as adjunct therapies in stroke management. This narrative review evaluates the current evidence supporting TCIM approaches for ischemic stroke, highlighting their potential neuroprotective, anti-inflammatory, antioxidant, and cerebrovascular effects. Particular emphasis is placed on well-studied botanical interventions such as Salvia miltiorrhiza Bunge [Lamiaceae; Salviae miltiorrhizae radix et rhizoma], Ginkgo biloba L. [Ginkgoaceae; Ginkgo folium], and Panax ginseng C.A. Mey. [Araliaceae; Ginseng radix]. The review discusses the mechanisms of action, clinical trial outcomes, and integration challenges, while underscoring the need for standardization, quality control, and rigorous scientific validation. This work aims to support informed decisions regarding the integration of evidence-based TCIM practices into conventional stroke care protocols.

来源:Front Pharmacol,查看原文。版权归原作者所有。

引用

  1. Sowmiya S, Begum RF, Dhivya LS, et al. Traditional, complementary, and integrative medicine in the management of ischemic stroke: a narrative review. Front Pharmacol. 2025. PMID: 40520194. doi:10.3389/fphar.2025.1561688

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。